Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 2456-2458, October 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Erratum (v34,p1523)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dawson, P. J.
Right arrow Articles by Fieldsteel, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dawson, P. J.
Right arrow Articles by Fieldsteel, A. H.

Genetic Factors in Chronic Remittent Friend Disease1

Peter J. Dawson and A. Howard Fieldsteel

Department of Pathology, University of Oregon Medical School, Portland, Oregon 97201 [P. J. D.], and Stanford Research Institute, Menlo Park, California 94025 [A. H. F.]

C57BL/6 and C57BL/Ks mice possess the alleles H-2b and H-2d, respectively. A study of Friend disease in C57BL/6 x DBA/2 F1 and C57BL/Ks x DBA/2 F1 mice showed that remittent disease occurred in the former hybrids and progressive disease in the latter. Since both hybrids have the same Fv-1 and Fv-2 genotypes the change in the character of the disease was ascribed to differences in the Rgv-1 gene located near the H-2 locus. The lymphatic leukemia-inducing virus that acts as helper for Friend virus was shown to replicate better in C57BL/Ks than in C57BL/6 mice, suggesting that Rgv-1 gene may regulate the occurrence of remissions through its action on the helper virus.

1 This work was supported in part by Grant DRF-1123 from the Damon Runyon Memorial Fund for Cancer Research, a grant from the American Cancer Society, Oregon Division, Inc., and by USPHS Grant CA-07868 from the National Cancer Institute.

Received 5/10/73. Accepted 6/28/73.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.